|
Ali, A; Mundle, S D; Ragasa, D et al. (1999) Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes. J Hematother Stem Cell Res 8:343-56
|
|
Mundle, S; Venugopal, P; Shetty, V et al. (1999) The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows. Int J Hematol 69:152-9
|
|
Preisler, H D; Bi, S; Venugopal, P et al. (1997) Cytokines, molecular biological abnormalities, and acute myelogenous leukemia. Leuk Res 21:299-312
|
|
Handa, H; Hegde, U P; Kotelnikov, V M et al. (1997) Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase. Leuk Res 21:479-89
|
|
Raza, A; Alvi, S; Borok, R Z et al. (1997) Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: the cause-effect relationship. Leuk Lymphoma 27:111-8
|
|
Raza, A; Alvi, S; Broady-Robinson, L et al. (1997) Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine. Exp Hematol 25:530-5
|
|
Handa, H; Hegde, U P; Kotelnikov, V M et al. (1997) The effects of 13-cis retinoic acid and interferon-alpha in chronic myelogenous leukemia cells in vivo in patients. Leuk Res 21:1087-96
|
|
Preisler, H D; Raza, A; Bonomi, P et al. (1997) Regrowth resistance as a likely significant contributor to treatment failure in drug-sensitive neoplastic diseases. Cancer Invest 15:358-68
|
|
Raza, A; Gregory, S A; Preisler, H D (1996) The myelodysplastic syndromes in 1996: complex stem cell disorders confounded by dual actions of cytokines. Leuk Res 20:881-90
|
|
Raza, A; Mundle, S; Shetty, V et al. (1996) A paradigm shift in myelodysplastic syndromes. Leukemia 10:1648-52
|
Showing the most recent 10 out of 18 publications
